RxDoctor Payments Data

Robert Billingsley

Psychiatry · Fayetteville, ARNPI 1790846947

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $1,828 of the $2,461 with a category attached, or 74.3%. Every reported general payment came from a single manufacturer, Neurocrine Biosciences, Inc..

$2,461in general payments, 2019–2025

Across 14 payments — averaging $175.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Neurocrine Biosciences, Inc.$2K
$5,948,107in research payments, 2019–2025

Across 936 payments — averaging $6354.82 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1.2M
  • Sunovion Pharmaceuticals Inc.$1M
  • Otsuka Pharmaceutical Development & Commercialization, Inc.$718K
  • Vanda Pharmaceuticals Inc.$607K
  • AbbVie$549K
  • Teva Pharmaceuticals USA, Inc.$532K
  • plus $1.3M from 15 others

What the payments were for

  • Travel & lodging$1,82874%
  • Food & beverage$63326%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Neurocrine Biosciences, Inc.14$2,461

How this compares

$2,461 in reported general payments places this provider in the 80th percentile of 235 psychiatry providers in Arkansas.

See all psychiatry providers in Arkansas

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clorazepate Dipotassium12$836
Venlafaxine Hcl ErVenlafaxine Hcl23$346
Clonazepam31$217
Amitriptyline Hcl17$127

Paid to pharmacies, not to this prescriber.

Other psychiatry in Fayetteville

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →